April 2, 2026

Science Chronicle

A Science and Technology Blog

April 2, 2026

Science Chronicle

A Science and Technology Blog

COVID-19

CoronavirusCOVID-19DiagnosticsSARS-CoV-2

IGIB uses mass spectrometer for coronavirus detection

IGIB researchers have been able to detect novel coronavirus using mass spectrometer. The detection is based on the presence of

Read More
CoronavirusCOVID-19SARS-CoV-2

Pre-existing memory T cells may reduce COVID-19 severity, but do not prevent infection

Pre-existing memory T cells that cross-react with SARS-CoV-2 may only reduce COVID-19 severity cannot prevent infection. The memory T cells

Read More
CoronavirusCOVID-19MERSPublic HealthSARS-CoV-2

Second case of confirmed coronavirus reinfection reported

Using genome sequencing researchers at Reno School of Medicine, University of Nevada have confirmed a case of coronavirus reinfection. Unlike

Read More
CoronavirusCOVID-19Genome sequencingPublic HealthSARS-CoV-2

A case of coronavirus reinfection in Hong Kong confirmed by genome sequencing

Using genome sequencing, researchers at the University of Hong Kong have found a rare instance of reinfection with novel coronavirus

Read More
Clinical trialCoronavirusCOVID-19FDAPublic HealthSARS-CoV-2

FDA grants emergency use authorisation for convalescent plasma, experts express concern

FDA grants emergency use authorisation for convalescent plasma even in the absence of evidence from randomised, controlled trial. Mr. Trump,

Read More
CoronavirusCOVID-19Public HealthSARS-CoV-2

Children have more coronavirus during early infection phase than hospitalised adults

Researchers found that children infected with novel coronavirus have viral load comparable with adults admitted to ICUs. But during the

Read More
Clinical trialCoronavirusCOVID-19Public HealthSARS-CoV-2Vaccines

Intranasal vaccination of a coronavirus candidate vaccine prevents infection

A new vaccine candidate construct using chimpanzee adenovirus carrying the full length of novel coronavirus spike protein as a transgene

Read More
CoronavirusCOVID-19Public HealthSARS-CoV-2

COVID-19: Saliva is a viable alternative to nasopharyngeal specimen in asymptomatic persons

  In a mass-screening study of 1,924 asymptomatic persons, self-collected saliva samples had sensitivity (92%) and specificity (over 99.9%) comparable

Read More
CoronavirusCOVID-19SARS-CoV-2Testing

With over 900 COVID-19 deaths per day for over a week, India crosses 50,000 toll

  If speed, low cost and constraints of molecular testing capacity are the reasons why many States have embraced rapid

Read More
CoronavirusCOVID-19Public HealthSARS-CoV-2Seroprevalence

Pune coronavirus sero survey results find 51.5% seroprevalence

  The sero survey carried out in five zones in Pune has found 51.5% seroprevalence, with the spread ranging from

Read More
CoronavirusCOVID-19DiagnosticsSARS-CoV-2Testing

FDA approves rapid, inexpensive saliva test for coronavirus

A rapid, inexpensive saliva test developed by Yale School of Public Health in partnership with NBA has high sensitivity. The

Read More
CoronavirusCOVID-19Public HealthSARS-CoV-2

Novel coronavirus-specific nutralising antibodies last at least for six months

  The researchers found that neutralizing antibodies were over 70% even at the end of six months. While IgG showed

Read More
CoronavirusCOVID-19Public HealthSARS-CoV-2

SARS-CoV-2-specific T cell immunity prevents recurrent severe COVID-19 disease

  The immune system elicits robust, broad and highly functional memory T cell responses once a person is infected with

Read More